We assessed the relationship between the expression level of ACE2 and the immune marker gene sets of different tumor TIICs, including T (functional and general) cells, B cells, monocytes, tumor‐associated macrophage (TAMs; M1 and M2), NK cells, neutrophils, and DCs (Table S7 and Figure 5). This evidence concerns the gene ACE2 and neoplasm.